SEC accuses Positron CEO of misleading investors
Regulators allege CEO Patrick G. Rooney diverted millions of dollars from a hedge fund into the struggling Fishers company without investors’ knowledge.
Life Science & Biotech
Articles
Purdue courts Silicon Valley partnerships
The office, at NASA Ames Research Center, in Mountain View, Calif., aims to commercialize Purdue-developed technology through partnerships with private industry.
JONES: Patent reform is mixed bag for life sciences companies
For Indiana’s life sciences sector, the change both raises hopes and creates challenges for continued growth.
Cancer-drug firm Endocyte to build commercial team in Indianapolis
Endocyte employs 12 people in Indianapolis and plans to add three or four more commercial executives there over the next year and a half as it anticipates approval of its ovarian cancer medication in Europe.
Drug shortages hit Lilly, Endocyte
The nation’s shortage of certain drugs is threatening to affect research trials being conducted by Eli Lilly and Co. and Endocyte Inc.
Insurer Humana’s quarterly profit climbs 13 percent
Humana Inc. raised its 2011 earnings forecast, following the lead set by other big insurers, including competitor WellPoint Inc.
Ortho firms pull back on doc payments
The number of payments in excess of $1 million didn’t change substantially from year to year, but orthopedic companies sharply cut their fees to surgeons who received the smallest amounts.
Dow Agro improves quarterly revenue, profit
Indianapolis-based Dow AgroSciences on Thursday reported record third-quarter sales of $1.2 billion, up 27 percent from the same period a year ago.
Indiana software firm growing with life sciences focus
RND Group fills development gaps for companies.
Drug theft is ongoing battle for pharmacies
Over the last 12 months, the Indiana Board of Pharmacy has conducted license litigation involving at least 35 pharmacy personnel statewide who’ve been accused of stealing drugs from work.
BioCrossroads seeds upstart medical device maker
BioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive developing an absorbable stent.
Profit falls at Lilly but meets Wall Street expectations
The Indianapolis-based drugmaker earned $1.24 billion in the three months ended Sept. 30, down 5 percent from the same quarter a year ago, even as revenue surged 9 percent.
Ex-Dow Agro scientist pleads guilty in espionage case
Kexue Huang faces up to 13 years in prison after pleading guilty Tuesday morning to sending trade secrets worth millions to China and Germany.
Cook Medical gets FDA panel’s backing for stent
The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg.
FDA: Cook Medical’s stent met efficacy, safety goals
Peripheral vascular devices, including stents, angioplasty balloons and synthetic grafts, generated $4.3 billion in global revenue last year and may earn $5.6 billion in 2014.
Biocrossroads lands $2.8 million Lilly Endowment grant
The advocate for the state’s life sciences industry has now pulled in more than $25 million from the endowment.
Cook family provides funding for Rose-Hulman bioscience lab
The $500,000 gift will help further a decade-long expansion of the school’s life sciences curriculum.
Federal judge nixes firm’s Bio Cremation lawsuit
A federal judge in Pittsburgh has thrown out a lawsuit filed by a Pittsburgh company that claimed its so-called "Bio Cremation" service — a flameless process to cremate remains — was being unfairly targeted by two Indiana competitors.
Lilly’s Alimta get favorable opinion for new use in Europe
If approved for continuation maintenance, Eli Lilly and Co.’s Alimta could be used for longer stretches in lung cancer patients, generating more revenue.